chevron_leftBack
As of 21 June 2026, Pharmosa Biopharm Inc. has a market cap of $155.2M USD, ranking #22670 globally and #1109 in Taiwan.
It ranks #2030 in the Healthcare sector, and #392 in the Biotechnology industry.
Key Stats
Market Cap
$155.2MUSD
4.91B TWD
Enterprise Value
$122.51MUSD
3.88B TWD
Revenue (TTM)
$2.13MUSD
67.27M TWD
EBITDA (TTM)
-$12.07MUSD
-382.04M TWD
Net Income (TTM)
-$12.14MUSD
-383.85M TWD
PS Ratio
73.0
PB Ratio
3.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Pei Kan
open_in_new
Employees
40
Founded
2000
Website
pharmosa.com.tw
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.6% | 1.4% | -4.8% | -18% | -32% | -27% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6875
國邑藥品科技股份有限公司
ISIN: TW0006875008
Shares Out.:
Shares Outstanding:
129.183M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
37.00 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Pharmosa Biopharm Inc.
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
3K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
938%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
594%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
368%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
287%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
268%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
117K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
103K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
30K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
28K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
27K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
27K%
33.71B CHF
|
37.2
|
chevron_leftBack